Today, the FDA approved a TROP-2–directed antibody and topoisomerase inhibitor conjugate for adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer ...
Outgoing FDA Commissioner raises concerns about safety of online-purchased compounded weight loss meds, highlighting challenges faced by the FDA, amidst contrasting views from nominee for Health and Human Services Secretary.
Novo Nordisk's high-dose semaglutide trial demonstrates a 20.7% weight reduction in overweight patients with obesity, promising new advancements in the treatment of obesity and diabetes.
A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.
The CDC emphasizes timely testing for avian influenza A in hospitalized patients to prevent delays and enhance rapid public health responses. Low person-to-person transmission risk has been reported with ongoing U.S. cases among farmworkers.
Reuters
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
"According to the predictive model, the proposed D2T PsA definition identified a small subset of patients with increased treatment difficulty. These findings highlight the need for refining the criteria to better define D2T PsA patients."
A patient presents with sudden-onset right-sided otalgia accompanied by vertigo, emesis, and auditory impairment. Your otoscope reveals an unexpected finding. What's your diagnosis?